David Komander
Impact in
- Molecular Biology top 0.05%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Glycosylation and Glycoproteins Research
- Cancer Research top 0.2%
- NF-κB Signaling Pathways
Papers in
-
- Ubiquitin and proteasome pathways 88
- Glycosylation and Glycoproteins Research 27
- Protein Kinase Regulation and GTPase Signaling 10
- Oncology 34
- Cancer-related Molecular Pathways 23
- Peptidase Inhibition and Analysis 13
- Co-authors
- Michael Rapé (1 shared paper)Kirby N. Swatek (12 shared papers)Michael J. Clague (4 shared papers)Sylvie Urbé (4 shared papers)Tycho E.T. Mevissen (13 shared papers)Dario R. Alessi (9 shared papers)Yogesh Kulathu (7 shared papers)Laura R. Pearce (1 shared paper)
- Journals
- Molecular Cell (13 papers)The EMBO Journal (8 papers)EMBO Reports (7 papers)Nature (7 papers)Nature Structural & Molecular Biology (6 papers)
- Partner nations
- United KingdomAustraliaGermany
In The Last Decade
David Komander
122 papers receiving 23.3k citations
David Komander's Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Biology 19.1k
- Cancer Research 3.0k
- Oncology 5.2k
- Immunology 4.0k
- Cell Biology 3.0k
Countries citing papers authored by David Komander
This map shows the geographic impact of David Komander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Komander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Komander more than expected).
Fields of papers citing papers by David Komander
This network shows the impact of papers produced by David Komander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Komander. The network helps show where David Komander may publish in the future.
Co-authors
The 25 scholars most cited alongside David Komander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Ubiquitin Code Hit paper breakdown → | 2012 | 2782 |
| 2 | Breaking the chains: structure and function of the deubiquitinases Hit paper breakdown → | 2009 | 1677 |
| 3 | Ubiquitin modifications Hit paper breakdown → | 2016 | 1548 |
| 4 | The nuts and bolts of AGC protein kinases Hit paper breakdown → | 2009 | 1012 |
| 5 | Mechanisms of Deubiquitinase Specificity and Regulation Hit paper breakdown → | 2017 | 792 |
| 6 | PDK1, the master regulator of AGC kinase signal transduction Hit paper breakdown → | 2004 | 643 |
| 7 | The emerging complexity of protein ubiquitination Hit paper breakdown → | 2009 | 636 |
| 8 | Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction Hit paper breakdown → | 2009 | 607 |
| 9 | Breaking the chains: deubiquitylating enzyme specificity begets function Hit paper breakdown → | 2019 | 605 |
| 10 | Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation Hit paper breakdown → | 2009 | 602 |
| 11 | Atypical ubiquitylation — the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages Hit paper breakdown → | 2012 | 543 |
| 12 | OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis Hit paper breakdown → | 2013 | 484 |
| 13 | 2009 | 468 | |
| 14 | 2001 | 406 | |
| 15 | Mechanism of phospho-ubiquitin-induced PARKIN activation Hit paper breakdown → | 2015 | 372 |
| 16 | 2013 | 371 | |
| 17 | 2013 | 352 | |
| 18 | 2018 | 303 | |
| 19 | 2010 | 278 | |
| 20 | 2013 | 274 |
About David Komander
David Komander is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Cancer Research, having authored 124 papers that have together received 23.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (88 papers), Autophagy in Disease and Therapy (28 papers), Glycosylation and Glycoproteins Research (27 papers), Cancer-related Molecular Pathways (23 papers), interferon and immune responses (18 papers), Peptidase Inhibition and Analysis (13 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and NF-κB Signaling Pathways (10 papers). The work is most often cited by research in Molecular Biology (19.1k citations), Cancer Research (3.0k citations), Oncology (5.2k citations), Immunology (4.0k citations) and Cell Biology (3.0k citations). David Komander has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include Michael Rapé, Kirby N. Swatek, Michael J. Clague, Sylvie Urbé, Tycho E.T. Mevissen, Dario R. Alessi, Yogesh Kulathu, Laura R. Pearce, Tobias Wauer and Stefan M.V. Freund. Their work appears in journals such as Molecular Cell, The EMBO Journal, EMBO Reports, Nature and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.